|
🦁
|
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease: an open-label multicentre randomised controlled trial
23 auth.
M. Jongsma,
M. Aardoom,
M. Cozijnsen,
M. van Pieterson,
T. D. de Meij,
M. Groeneweg,
O. Norbruis,
V. Wolters,
H. V. van Wering,
I. Hojsak,
...
K. Kolho,
T. Hummel,
J. Stapelbroek,
C. van der Feen,
P. V. van Rheenen,
M. V. van Wijk,
Sarah T A Teklenburg-Roord,
M. Schreurs,
D. Rizopoulos,
M. Doukas,
J. Escher,
J. Samsom,
L. de Ridder
|
6 |
2020 |
6
🦁
|
|
🦁
|
Infliximab in young paediatric IBD patients: it is all about the dosing
18 auth.
M. Jongsma,
D. Winter,
H. Huynh,
L. Norsa,
S. Hussey,
K. Kolho,
J. Bronský,
A. Assa,
Shlomi Cohen,
R. Lev-Tzion,
...
S. Van Biervliet,
D. Rizopoulos,
T. D. de Meij,
D. Shouval,
E. Wine,
V. Wolters,
C. Martinez-Vinson,
L. de Ridder
|
5 |
2020 |
5
🦁
|
|
🐜
|
Development and Validation of the Mucosal Inflammation Noninvasive Index For Pediatric Crohn's Disease.
16 auth.
M. Cozijnsen,
Assaf Ben Shoham,
B. Kang,
B. Choe,
Y. Choe,
M. Jongsma,
R. Russell,
F. Ruemmele,
J. Escher,
L. de Ridder,
...
S. Koletzko,
J. Martín-de-Carpi,
J. Hyams,
T. Walters,
A. Griffiths,
D. Turner
|
5 |
2019 |
5
🐜
|
|
🐬
|
Vedolizumab Trough Levels in Children With Anti-Tumor Necrosis Factor Refractory Inflammatory Bowel Disease
M. Aardoom,
M. Jongsma,
A. de Vries,
J. Wolthoorn,
L. de Ridder,
J. Escher
|
3 |
2020 |
3
🐬
|
|
🦁
|
Serum Immune Profiling in Paediatric Crohn’s Disease Demonstrates Stronger Immune Modulation With First-Line Infliximab Than Conventional Therapy and Pre-Treatment Profiles Predict Clinical Response to Both Treatments
10 auth.
M. Jongsma,
L. Costes,
I. Tindemans,
M. Cozijnsen,
R. H. C. Raatgreep,
M. van Pieterson,
...
Yunlei Li,
J. Escher,
L. de Ridder,
J. Samsom
|
3 |
2023 |
3
🦁
|
|
🦁
|
The use of biosimilars in paediatric inflammatory bowel disease
M. Jongsma,
A. Vulto,
L. de Ridder
|
3 |
2017 |
3
🦁
|
|
🦁
|
Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset moderate-to-severe luminal paediatric Crohn’s disease
15 auth.
M. Jongsma,
S. Vuijk,
M. Cozijnsen,
M. van Pieterson,
O. Norbruis,
M. Groeneweg,
V. Wolters,
H. V. van Wering,
I. Hojsak,
K. Kolho,
...
M. V. van Wijk,
Sarah T A Teklenburg-Roord,
T. D. de Meij,
J. Escher,
L. de Ridder
|
2 |
2022 |
2
🦁
|
